BURN-X cpr pell 20 mg 14 pce

7680688140125 CH-68814 A02BC05 04.99.0.
BURN-X cpr pell 20 mg 14 pce
BURN-X cpr pell 20 mg 14 pce
BURN-X cpr pell 20 mg 14 pce
1 / 3
google

Details

Product number
6881401
CPT
-
Packaging group
14
Unit
Tablette(n)
Composition
esomeprazolum 20 mg ut esomeprazolum magnesicum dihydricum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas, polysorbatum 80, talcum, triethylis citras, hypromellosum, sacchari sphaerae, magnesii stearas, hydroxypropylcellulosum, glyceroli monostearas 40-55, polysorbatum 80, cellulosum microcristallinum, povidonum, macrogolum 6000, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), E 172 (flavum) pro compresso obducto corresp. natrium 0.082 mg.

Articles (1)

Burn-X, magensaftresistente Tabletten
Magensaftresistente Tabletten
14
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/08/2025
Patient information leaflet
Français
21/08/2025
Patient information leaflet
Italien
21/08/2025
Professional SmPC
Allemand
21/08/2025
Professional SmPC
Français
21/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
0.082 MG Substance HBESI

Authorization holder

axapharm ag

6340 Baar

Authorization information

Swissmedic authorization number
68814
Drug name
Burn-X, magensaftresistente Tabletten
Galenic form
MATB
ATC Code
A02BC05
Authorization status
Z
Dispensation category
D
First authorization
17/02/2022
Authorization expiration date
31/12/9999
IT number
04.99.0.
Domain
Human medicine
Field of application
Protonenpumpenblocker

Packaging details

Description (FR)
BURN-X cpr pell 20 mg 14 pce
Description (DE)
BURN-X Filmtabl 20 mg 14 Stk
Market launch
17/02/2022
Narcotic (BTM)
No

Available generics

Esomep, MUPS-Tabletten
CHF 16.25
View
Esomep, MUPS-Tabletten
CHF 30.25
View
Esomep, MUPS-Tabletten
CHF 40.75
View
Esomep, MUPS-Tabletten
CHF 51.90
View
Esomep, MUPS-Tabletten
CHF 17.10
View
Esomep, MUPS-Tabletten
CHF 31.55
View
Esomep, MUPS-Tabletten
CHF 45.95
View
Esomep, MUPS-Tabletten
CHF 59.65
View
Esomeprazol Axapharm, magensaftresistente Tabletten
CHF 15.35
View
Esomeprazol Axapharm, magensaftresistente Tabletten
CHF 28.40
View

Other packaging sizes

BURN-X cpr pell 20 mg 7 pce
7 TABL
View